Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1)

BACKGROUND: Few patients with pancreatic cancer may be candidates for immediate surgical resection at the initial diagnosis. Even if patients with borderline resectable pancreatic cancer (BRPC), micrometastases may occur before surgery. Therefore, neoadjuvant therapy is vital for improved survival,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Suizhi, Zhu, Xiaofei, Shi, Xiaohan, Cao, Kai, Bian, Yun, Jiang, Hui, Wang, Kaixuan, Guo, Shiwei, Zhang, Huojun, Jin, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437889/
https://www.ncbi.nlm.nih.gov/pubmed/30917842
http://dx.doi.org/10.1186/s13014-019-1254-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437889/
https://www.ncbi.nlm.nih.gov/pubmed/30917842
http://dx.doi.org/10.1186/s13014-019-1254-8

Ejemplares similares